arrow
K

Ken J. Ishii

the university of tokyo
H指数:82
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A poorly reactogenic lipid nanoparticle-mRNA vaccine unveils an innate immune pathway for adverse reactions

一种反应原性较差的脂质纳米颗粒-mRNA疫苗揭示不良免疫反应的固有免疫通路

2026-04-160
OAAI
IL-1 delineates squalene-based adjuvant efficacy and reactogenicity in a cell-type-specific manner

IL-1以细胞类型特异性的方式界定了角鲨烯基佐剂的效能和反应原性。

2026-03-300
OAAI
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis

通过核吞噬作用从死亡细胞中提取核DNA以引发cGAS-IFN-I反应

2026-02-180
OAAI
Identification of Histone Deacetylase Inhibitor Targeting Type I Interferon and B Cell Abnormalities in Systemic Lupus Erythematosus

系统性红斑狼疮中靶向I型干扰素和B细胞异常的组蛋白去乙酰化酶抑制剂的鉴定

2026-02-010
OAAI
Long-term immunoprophylaxis by TLR9 ligand mediates macrophage-ILC cross-talk against respiratory viral infection

TLR9配体介导的长期免疫预防通过巨噬细胞-ILC相互作用抵抗呼吸道病毒感染

2026-01-010
PRE
Resident alveolar macrophages are highly susceptible to the induction of RIPK1/RIPK3-mediated necroptosis which promote efficient pulmonary immune response

定居肺泡巨噬细胞极易受到RIPK1/RIPK3介导的坏死性凋亡的诱导,这促进了高效的肺部免疫反应。

2025-12-220
OAAI
NOX2-Dependent Phagocyte Signaling Mediates Silica-Induced Murine Lung Injury via Macrophage-Neutrophil Interactions

NOX2依赖的吞噬细胞信号介导二氧化硅诱导的小鼠肺损伤,通过巨噬细胞-中性粒细胞相互作用。

2025-12-170
OAAI
An adjuvant database for preclinical evaluation of vaccines and immunotherapeutics

用于疫苗和免疫治疗药物预临床评价的佐剂数据库

2025-08-110
OAAI
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation

OTUD3通过抑制微生物介导的STING活化来预防溃疡性结肠炎

2025-07-180
PRE
Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpox

LC16m8疫苗的免疫学分析:对猴痘的预临床和早期临床见解

2025-05-010
PRE
Immunogenicity, safety, and tolerability of a β-glucan-CpG-adjuvanted respiratory syncytial virus vaccine in Japanese healthy participants aged 60 to 80 years: A phase 2, randomized, double-blind, dose-finding study

在60至80岁的日本健康参与者中,β-葡聚糖-CpG佐剂呼吸道合胞病毒疫苗的免疫原性,安全性和耐受性: 一项2期,随机,双盲,剂量发现研究

2025-04-210
OA